We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FARM
951
DELISTED
Farmer Brothers
FARM
$362K 0.01%
77,200
+6,400
+9% +$36.1K
TCRX icon
952
TScan Therapeutics
TCRX
$49.9M
$362K 0.01%
115,000
– –
LEGH icon
953
Legacy Housing
LEGH
$687M
$359K 0.01%
+27,500
New +$464K
PBYI icon
954
Puma Biotechnology
PBYI
$413M
$359K 0.01%
126,100
-50,000
-28% -$124K
ARL icon
955
American Realty Investors
ARL
$242M
$358K 0.01%
25,197
– –
BBGI icon
956
Beasley Broadcasting Group
BBGI
$42.8M
$358K 0.01%
13,991
– –
CALX icon
957
Calix
CALX
$2.36B
$358K 0.01%
10,500
– –
GTIM icon
958
Good Times Restaurants
GTIM
$15M
$357K 0.01%
118,600
– –
POWI icon
959
Power Integrations
POWI
$3.29B
$353K 0.01%
4,700
– –
SEM
960
DELISTED
Select Medical
SEM
$352K 0.01%
27,654
– –
MACK
961
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$352K 0.01%
59,200
– –
IOBT
962
DELISTED
IO Biotech
IOBT
$350K 0.01%
+75,000
New +$459K
AVEO
963
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$348K 0.01%
+53,000
New +$257K
VOR icon
964
Vor Biopharma
VOR
$1.28B
$345K 0.01%
+3,470
New +$355K
ATXS
965
DELISTED
Astria Therapeutics
ATXS
$343K 0.01%
114,279
+50,000
+78% +$224K
CYPH
966
Cypherpunk Technologies Inc
CYPH
$71.7M
$343K 0.01%
29,830
+13,120
+79% +$170K
LPCN icon
967
Lipocine
LPCN
$17.6M
$341K 0.01%
25,039
+14,635
+141% +$228K
GHL
968
DELISTED
Greenhill & Co., Inc.
GHL
$339K 0.01%
36,800
-22,600
-38% -$277K
WTT
969
DELISTED
Wireless Telecom Group, Inc.
WTT
$338K 0.01%
256,258
– –
KINS icon
970
Kingstone Companies
KINS
$301M
$337K 0.01%
85,500
– –
HYPR icon
971
Hyperfine
HYPR
$97.5M
$335K 0.01%
+150,000
New +$442K
USIO icon
972
Usio Inc
USIO
$63.7M
$331K 0.01%
136,400
– –
IDN icon
973
Intellicheck
IDN
$76.8M
$330K 0.01%
163,300
– –
BRN icon
974
Barnwell Industries
BRN
$14.5M
$329K 0.01%
140,030
+70,797
+102% +$195K
FEIM icon
975
Frequency Electronics
FEIM
$815M
$329K 0.01%
45,000
– –
37 38
39
40 41

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.